Cigna Group (CI)

Over the past six months, Cigna's stock price has fluctuated, with a share price of $279.31 as of May 4, 2026, a 16.13% decline from May 5, 2025, and a 52-week range between $239.51 and $338.89. Key events include the Q4 2025 earnings report on February 5, 2026, where Cigna reported revenue of $72.47 billion and adjusted EPS of $8.08, exceeding estimates and increasing its quarterly dividend. The Q1 2026 earnings report on April 30, 2026, showed revenues increasing 5% to $68.5 billion and adjusted income from operations of $2.1 billion, raising the 2026 outlook. Cigna also announced its planned exit from ACA exchanges and is exploring strategic alternatives for eviCore. Goldman Sachs raised its price target on Cigna to $340 with a "buy" rating in May 2026.

Demand seasonality for Cigna's products and services is evident in various aspects of its operations. The Cigna Healthcare MCR was 79.8% for the first quarter of 2026, compared to 82.2% for the first quarter of 2025, reflecting the impact of the HCSC transaction, with sequential increases in net medical costs payable reflecting typical stop-loss seasonality. The company expects second-quarter pretax adjusted earnings seasonality for Evernorth to be similar to historical patterns. The broader healthcare sector generally experiences seasonal strength from April 25 to December 4. Client renewals and investments in new models in the Pharmacy Benefit Services segment can influence earnings and demand, and the planned exit from ACA exchanges will impact enrollment figures.

The Cigna Group is a global health services company offering health insurance and related services, operating in the managed healthcare and insurance sector through its Evernorth Health Services and Cigna Healthcare segments. Its offerings include medical, dental, disability, life, and accident insurance, primarily through employers and individual plans. Pharmacy benefits management is provided through Evernorth Health Services, encompassing drug claim adjudication, retail pharmacy network administration, and specialty pharmacy services. Cigna also provides behavioral health programs, Medicare and Medicaid plans, and health and wellness programs, though it is selling its Medicare Advantage and related businesses to HCSC.

The Cigna Group has sales capabilities in over 30 countries, serving more than 185 million customer relationships worldwide. While its primary operations are in the United States, Cigna Global Health Benefits has operations in Visalia, California; Greenock, Scotland; Shanghai, China; and Antwerp, Belgium, with sales offices across North America, Europe, Asia, and the Middle East. In the U.S., Cigna Healthcare offers individual and family medical plans in 11 states and dental plans in 49 states, with specific states and counties serviced for medical products.

Cigna Healthcare received positive recognition for its digital experience, ranking No. 1 in the JD Power 2026 U.S. Healthcare Digital Experience Study for the second consecutive year. However, Cigna faces scrutiny as it explores strategic alternatives for eviCore amid concerns about care delays and denials, potentially impacting its reputation. Cigna has historically faced controversies, including lawsuits and allegations of fraud.

Ownership of The Cigna Group is predominantly institutional, with approximately 91.03% of shares held by institutional investors and hedge funds. Major institutional owners include The Vanguard Group, Inc., BlackRock, Inc., and State Street Corporation. Individual investors hold about 10% ownership, while insiders own under 1% of the company.